Synthetic Biologics Inc. | Ownership
Companies that own Synthetic Biologics Inc.
Geode Capital Management LLC
617,136
16.25%
599,504
0%
06/30/2018
The Vanguard Group, Inc.
132,740
3.49%
143
0%
06/30/2018
MSD Partners LP
117,667
3.1%
0
0.01%
06/30/2018
William Blair Investment Management LLC
63,290
1.67%
6,695
0%
06/30/2018
683 Capital Management LLC
42,857
1.12%
0
0.01%
06/30/2018
BlackRock Fund Advisors
38,201
1.01%
82
0%
06/30/2018
Millennium Management LLC
5,770
0.15%
-7,758
0%
06/30/2018
Securities America Advisors, Inc.
5,000
0.13%
0
0%
06/30/2018
Northern Trust Investments, Inc.
4,925
0.13%
0
0%
06/30/2018
Creative Planning, Inc.
4,743
0.13%
-257
0%
06/30/2018
| Address |
9605 Medical Center Drive
Rockville Maryland 20850
United States
|
|
Employees
|
- |
| Website |
http://www.syntheticbiologics.com |
| Updated |
07/08/2019 |
| Synthetic Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-010 and SYN-004. The SYN-010, which is intended to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation. |
